Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating oral ulcer

An ulcer and drug technology, applied in the field of drug formulations for the treatment of oral ulcers, can solve problems such as bad taste, lack of trace elements, irritation, etc., and achieve the effects of treating autoimmune damage, good taste, and promoting healing

Inactive Publication Date: 2010-06-09
杨文臣
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] 3. It is related to the lack of B vitamins in some patients, (such as VB2) lack of trace elements, such as zinc, etc.
In addition to the factors of medicine, if the diagnosis is inaccurate and the medicine is deviated, it will also cause the treatment to be ineffective.
[0007] The three kinds of topical ulcer drugs listed above are the drugs with better effect on the treatment of oral ulcers currently on the market. In fact, their curative effects are very limited, and they are effective for some patients, while the curative effect for most ulcer patients is very poor.
Other medicines such as Bingboran, Xileisan, etc. are even less effective in treating oral ulcers
There is no drug on the market that can cure oral ulcers caused by the three major causes
Moreover, the current medicines for the treatment of oral ulcers have a bad mouthfeel, often with sour tongue, irritation and weird taste.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: The pharmaceutical composition formula of the present invention is: 4.5 mg of dexamethasone acetate, 1000 mg of nystatin, 240 mg of vitamin B, 0.75 mg of licorice zinc, 5 mg of potassium iodide, and the powder according to the composition ratio will be made into powder or tablet or capsules.

Embodiment 2

[0024] Embodiment 2 The pharmaceutical ingredient formula of the present invention is: dexamethasone acetate 1.5 mg, nystatin 850 mg, vitamin B 215 mg, licorice zinc 1 mg, potassium iodide 3 mg, and the powder according to the composition ratio is made into powder, tablet or capsule .

Embodiment 3

[0025] Embodiment 3 The pharmaceutical ingredient formula of the present invention is: 6 mg of dexamethasone acetate, 150 mg of nystatin, 210 mg of vitamin B, 0.25 mg of licorice zinc, and 2 mg of potassium iodide. .

[0026] The preparation method of the present invention is: the formula drug of the present invention can be bought tablet at present on the market, every kind of tablet is ground into 70-150 purpose powder, mixes evenly according to the formula of the present invention and becomes the medicine of the present invention, can be prepared according to the formula of the present invention. The proportioned powder of this ingredient is made into powder or tablet or capsule.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating oral ulcer, comprising the components: 1.5-6mg of dexamethasone acetate, 150-1000mg of nysfungin, 10-40mg of vitamin B2, 0.25-1mg of licorzinc and 2-5mg of potassium iodide, and the powder prepared by the component mixture ratio is made into pulvis, tablets or capsules. The medicine overcomes the limitation of other clinical medicines, and has good treatment effect for oral ulcer caused by three pathogenies of the oral ulcer. Furthermore, the medicine has good taste, causes no pain when being contacted with ulcer surface, and is well accepted by patients.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical formulations for treating oral ulcer disease. Background technique [0002] For oral ulcers, the current medical community is not very clear about its specific etiology, but the academic community generally believes that it is mainly caused by the following three factors: [0003] 1. Oral ulcers are related to the patient's autoimmune damage; [0004] 2. It is related to microbial infection in some patients (such as infection with fungi, bacteria or viruses); [0005] 3. It is related to the lack of B vitamins in some patients, (such as VB2) and the lack of trace elements such as zinc. There are also other etiologies, but their proportion is small. [0006] According to medical research, the above three aspects are the main causes of oral ulcers in patients. Some patients may have only a certain cause of disease to cause ulcers, while most patients have two or more causes of disease and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/484A61K9/14A61K9/20A61K9/48A61P1/02A61K33/18A61K31/7048A61K31/573A61K31/525
Inventor 杨文臣
Owner 杨文臣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products